[go: up one dir, main page]

CN106167815A - The Preparation method and use of it dimension streptozotocin derivative - Google Patents

The Preparation method and use of it dimension streptozotocin derivative Download PDF

Info

Publication number
CN106167815A
CN106167815A CN201610374253.4A CN201610374253A CN106167815A CN 106167815 A CN106167815 A CN 106167815A CN 201610374253 A CN201610374253 A CN 201610374253A CN 106167815 A CN106167815 A CN 106167815A
Authority
CN
China
Prior art keywords
glucosyl
tenvermectins
preparation
culture medium
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610374253.4A
Other languages
Chinese (zh)
Inventor
万绪
王继栋
陈安良
张辉
张绍勇
齐欢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiyang College of Zhejiang A&F University
Original Assignee
Jiyang College of Zhejiang A&F University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiyang College of Zhejiang A&F University filed Critical Jiyang College of Zhejiang A&F University
Priority to CN201610374253.4A priority Critical patent/CN106167815A/en
Publication of CN106167815A publication Critical patent/CN106167815A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明属于生物技术领域,具体涉及天维菌素衍生物的制备方法及用途,包括1)制备红色糖多孢菌种子液;2)制备天维菌素衍生物。本发明的方法制备天维菌素衍生物的转化率高,经济可行。本发明制备的天维菌素衍生物用于制备防治农林害虫或害螨药物,且该药物在防治农林害虫或害螨时具有优异的效果。The invention belongs to the field of biotechnology, and in particular relates to a preparation method and application of an asvermectin derivative, including 1) preparing a Saccharopolyspora rubrum seed liquid; The method of the invention has high conversion rate for preparing asvermectin derivatives and is economical and feasible. The asvermectin derivatives prepared by the invention are used to prepare medicines for preventing and controlling agricultural and forestry pests or harmful mites, and the medicine has excellent effects in preventing and controlling agricultural and forestry pests or harmful mites.

Description

天维菌素衍生物的制备方法及用途Preparation method and application of asvermectin derivatives

技术领域technical field

本发明属于生物技术领域,具体涉及4″-O-glucosyl tenvermectins A/B及其利用微生物转化制备的方法和在制备防治农林害虫和害螨药物中的应用。The invention belongs to the field of biotechnology, and in particular relates to 4″-O-glucosyl tenvermectins A/B and its preparation method through microbial transformation and its application in the preparation of medicines for preventing and controlling agricultural and forestry pests and pest mites.

背景技术Background technique

天维菌素(Tenvermectin)是新型十六元大环内酯类抗生素,具有广谱、高效、低毒、剂量小、使用更安全等特点,其中天维菌素A/B的化学结构式如下:Tenvermectin (Tenvermectin) is a new type of 16-membered macrolide antibiotic, which has the characteristics of broad spectrum, high efficiency, low toxicity, small dose, and safer use. The chemical structure formula of Tenvermectin A/B is as follows:

经活性测定,其与阿维菌素、伊维菌素和米尔贝霉素相比,对蚜虫、螨、鳞翅目类害虫和其它危害作物的害虫以及家畜肠道寄生虫都具有更好的防治效果,是一种前景非常好的新一代环保型杀虫剂。After activity determination, compared with abamectin, ivermectin and milbemycin, it has a better effect on aphids, mites, lepidopteran pests and other pests that harm crops and livestock intestinal parasites. It is a new generation of environmentally friendly insecticide with very promising prospects.

微生物转化是通过微生物细胞将复杂的底物进行结构修饰,也就是利用微生物代谢过程中产生的某个或某一系列的酶对底物特定部位(基团)进行 催化反应,使底物分子结构变化为相类似的另一种化合物。微生物转化具备反应定向,产物较为单一,副反应少,生物量积累快、转化时间短、转化酶表达效率高,反应条件温和,安全环保等优点,是天然活性化合物进行结构修饰的的一种便利手段。以微生物转化天维菌素A/B,得到新的、结构类似的活性化合物,对拓展开发利用新一代天维菌素大环内酯类药物具有重要意义。Microbial transformation is to modify the structure of complex substrates through microbial cells, that is, to use a certain enzyme or a series of enzymes produced in the metabolic process of microorganisms to catalyze specific parts (groups) of substrates to make the molecular structure of substrates Change to another similar compound. Microbial transformation has the advantages of reaction orientation, single product, less side reactions, fast biomass accumulation, short transformation time, high expression efficiency of invertase, mild reaction conditions, safety and environmental protection, etc. It is a convenient method for structural modification of natural active compounds. means. The conversion of asvermectin A/B by microorganisms to obtain new active compounds with similar structures is of great significance for the development and utilization of a new generation of asvermectin macrolide drugs.

发明内容Contents of the invention

本发明提供4″-O-glucosyl tenvermectins A/B的制备方法及用途,本发明通过微生物转化天维菌素得到一种新的天维菌素衍生物,具有良好的杀虫杀螨效果,具有开发成新一代环保杀虫剂的潜力。The invention provides a preparation method and application of 4″-O-glucosyl tenvermectins A/B. The invention obtains a new tenvermectin derivative through microbial transformation of tenvermectins, which has good insecticidal and acaricidal effects, and has Potential to be developed into a new generation of environmentally friendly insecticides.

本发明的技术方案是提供一种4″-O-glucosyl tenvermectins A/B的制备方法,包括如下步骤:The technical scheme of the present invention is to provide a kind of preparation method of 4 "-O-glucosyl tenvermectins A/B, comprise the steps:

1)制备红色糖多孢菌种子液:取保藏号为ATCC 11635的红色糖多孢菌菌株Saccharopolyspora erythraea,划线接种于YMS固体培养基上,在20-28℃的恒温培养箱中培养5-7天,将活化后的菌种转接于液体培养基中,置于20-28℃,250rpm的水平摇床中培养40小时,得到种子液;1) Preparation of Saccharopolyspora erythraea seed liquid: take the Saccharopolyspora erythraea strain Saccharopolyspora erythraea with the preservation number ATCC 11635, inoculate it on the YMS solid medium by streaking, and cultivate it in a constant temperature incubator at 20-28°C for 5- After 7 days, the activated strains were transferred to the liquid medium, placed in a horizontal shaker at 20-28°C and 250 rpm for 40 hours, and the seed liquid was obtained;

2)制备4″-O-glucosyl tenvermectins A/B:将种子液转接于转化培养基中,培养24小时后加入用有机溶剂溶解的转化底物天维菌素A/B,在20-28℃,250rpm的条件下转化培养150小时后,得到发酵液;采用萃取剂萃取发酵液并回收萃取剂后纯化分离得到4″-O-glucosyl tenvermectins A/B纯品;所述4″-O-glucosyl tenvermectins A/B的化学结构表征为:2) Preparation of 4″-O-glucosyl tenvermectins A/B: transfer the seed solution to the transformation medium, and after culturing for 24 hours, add the transformation substrate tenvermectins A/B dissolved in an organic solvent, and then add the transformation substrate tenvermectins A/B dissolved in an organic solvent, and then transfer the seed liquid to the transformation medium, and then add the transformation substrate tenvermectins A/B dissolved in an organic solvent, at 20-28 ℃, 150 hours under the condition of 250rpm, the fermentation broth was obtained; the extractant was used to extract the fermentation broth and the extractant was recovered, purified and separated to obtain pure 4″-O-glucosyl tenvermectins A/B; the 4″-O- The chemical structure of glucosyl tenvermectins A/B is characterized by:

本发明提供的4″-O-glucosyl tenvermectins A/B的制备方法,该方法通过发酵培养红色糖多孢菌Saccharopolyspora erythraea(ATCC 11635),然后在一定时间加入底物天维菌素A/B(tenvermectins A/B)后继续培养150h,最后经过提取分离得到十六元大环内酯类化合物4″-O-glucosyl tenvermectins A/B。The preparation method of 4 "-O-glucosyl tenvermectins A/B provided by the present invention, the method is by fermenting and cultivating red sugar polyspora Saccharopolyspora erythraea (ATCC 11635), then adding substrate tenvermectins A/B ( tenvermectins A/B) and then continue to cultivate for 150h, and finally obtain sixteen-membered macrolide compound 4″-O-glucosyl tenvermectins A/B through extraction and separation.

红色糖多孢菌菌株在YMS固体培养基上呈浅黄褐色或灰黄色,孢子球形、卵圆形,表面光滑。红色糖多孢菌是具有菌丝及孢子分化的革兰氏阳性菌G(+),会产生由表面多刺的孢子组成的短孢子链。产生孢子的方式是由营养气生菌丝末端开始卷曲,然后菌丝会产生隔膜,将菌丝分为几段,接着逐渐加厚隔膜成壁,最后形成圆形孢子释放。该菌购于“美国标准生物品收藏中心”,保藏号为:ATCC 11635。The strain of Saccharopolyspora rubrum is light yellow-brown or gray-yellow on YMS solid medium, and the spores are spherical, oval, and smooth. Saccharopolyspora rubrum is a Gram-positive bacterium G(+) with hyphal and spore-differentiating, producing short spore chains consisting of spores with spiny surfaces. The way to produce spores is that the end of the vegetative aerial mycelium begins to curl, and then the hyphae will produce a septum, divide the mycelium into several sections, then gradually thicken the septum to form a wall, and finally form a circular spore to release. The fungus was purchased from the "American Standard Biological Collection" with a preservation number of ATCC 11635.

作为优选的技术方案,所述步骤1)的液体培养基的制备方法为:取葡萄 糖10g、酵母抽提物2g、牛肉抽提物2g和蛋白胨3g,用蒸馏水定容至1000ml后,用1mol/l的NaOH调节pH至7.0,采用250ml三角瓶每瓶分装40ml,在121℃、0.15MPa条件下灭菌20min。As a preferred technical scheme, the preparation method of the liquid medium in step 1) is as follows: take 10 g of glucose, 2 g of yeast extract, 2 g of beef extract and 3 g of peptone, set the volume to 1000 ml with distilled water, and then use 1 mol/ 1 of NaOH to adjust the pH to 7.0, use 250ml Erlenmeyer flasks to pack 40ml each, and sterilize at 121°C and 0.15MPa for 20min.

作为优选的技术方案,所述步骤2)的转化培养基包括碳氮比不同的M-1培养基、M-2培养基、M-3培养基和M-4培养基,其中,As a preferred technical solution, the transformation medium in step 2) includes M-1 medium, M-2 medium, M-3 medium and M-4 medium with different carbon-nitrogen ratios, wherein,

M-1培养基的组分为:葡萄糖5g、红糖10g、胰蛋白胨5g、酵母抽提物2.5g、乙二胺四乙酸钠0.036g、甜菜碱1.2g和丙酸钠0.11g;The components of M-1 medium are: glucose 5g, brown sugar 10g, tryptone 5g, yeast extract 2.5g, sodium edetate 0.036g, betaine 1.2g and sodium propionate 0.11g;

M-2培养基的组分为:工业葡萄糖44g、牛肉膏5.0g、蛋白胨6.0g、酵母抽提物4g、酪蛋白胨3.0g、热炸黄豆饼粉11.0g、NaCl 1.5g和K2HPO40.5g;The components of the M-2 medium are: industrial glucose 44g, beef extract 5.0g, peptone 6.0g, yeast extract 4g, casein peptone 3.0g, hot fried soybean cake powder 11.0g, NaCl 1.5g and K 2 HPO 4 0.5g;

M-3培养基的组分为:葡萄糖50g、黄豆饼粉5g、酵母抽提物5g、蛋白胨4g、NaCl 5g、K2HPO42g和KH2PO41g;The components of the M-3 medium are: glucose 50g, soybean cake powder 5g, yeast extract 5g, peptone 4g, NaCl 5g, K 2 HPO 4 2g and KH 2 PO 4 1g;

M-4培养基的组分为:工业葡萄糖50g、NaCl 5g、(NH4)2SO42g、CaCO36g和大豆粉30g;The components of the M-4 medium are: industrial glucose 50g, NaCl 5g, (NH 4 ) 2 SO 4 2g, CaCO 3 6g and soybean powder 30g;

以上组分用蒸馏水定容至1000ml后,用1mol/l的NaOH调节pH至7.0-7.2,250ml三角瓶每瓶分装40ml,在121℃、0.15MPa条件下灭菌20min。After the above components were adjusted to 1000ml with distilled water, the pH was adjusted to 7.0-7.2 with 1mol/l NaOH, and each 250ml Erlenmeyer flask was filled with 40ml, and sterilized at 121°C and 0.15MPa for 20min.

本发明还涉及通过改变转化培养基组分,提高十六元大环内酯类化合物4″-O-glucosyl tenvermectins A/B的转化率的方法。将种子液转接于上述四种不同转化培养基(M-1培养基、M-2培养基、M-3培养基和M-4培养基)中,这四种转化培养基的碳源均以葡萄糖为基础下,氮源多样化,且具备必要的 微量元素,在其他转化条件均不变的情况下,比较在四组不同培养基条件下天维菌素A/B通过微生物转化为4″-O-glucosyl tenvermectins A/B的转化率的高低。结果表明转化培养基M-1的转化率最低,而转化培养基M-4(碳源为单一葡萄糖,碳氮比约为1.5:1)的转化率最高(详细情况见实施例),因此当转化培养基碳源选为葡萄糖,碳氮比约为1.5:1时,有利于天维菌素A/B微生物转化为4″-O-glucosyltenvermectins A/B。The present invention also relates to a method for improving the conversion rate of the sixteen-membered macrolide compound 4″-O-glucosyl tenvermectins A/B by changing the transformation medium components. The seed solution is transferred to the above four different transformation cultures In the medium (M-1 medium, M-2 medium, M-3 medium and M-4 medium), the carbon source of these four transformation mediums is based on glucose, and the nitrogen source is diversified, and With the necessary trace elements, under the condition that other transformation conditions remain unchanged, compare the conversion rate of astramectin A/B to 4″-O-glucosyl tenvermectins A/B by microorganisms under four different medium conditions high and low. The result shows that the conversion rate of conversion medium M-1 is the lowest, and the conversion rate of conversion medium M-4 (the carbon source is a single glucose, and the carbon-nitrogen ratio is about 1.5: 1) is the highest (detailed situation sees embodiment), so when Glucose is selected as the carbon source of the transformation medium, and when the carbon-to-nitrogen ratio is about 1.5:1, it is beneficial for the microbial transformation of asvermectin A/B into 4″-O-glucosyltenvermectins A/B.

作为优选的技术方案,所述步骤2)的有机溶剂包括甲醇、乙醇、DMSO中的一种或几种。As a preferred technical solution, the organic solvent in step 2) includes one or more of methanol, ethanol, and DMSO.

作为优选的技术方案,所述步骤2)的萃取剂包括乙酸乙酯、正丁醇、醋酸异丁酯、乙醚、石油醚、二氯甲烷或三氯甲烷中的一种或几种。As a preferred technical solution, the extractant in step 2) includes one or more of ethyl acetate, n-butanol, isobutyl acetate, ether, petroleum ether, dichloromethane or chloroform.

作为优选的技术方案,所述步骤2)的纯化包括反相高效液相色谱层析。As a preferred technical solution, the purification in step 2) includes reverse-phase high-performance liquid chromatography.

作为优选的技术方案,所述步骤2)的纯化还包括硅胶柱层析。As a preferred technical scheme, the purification in step 2) also includes silica gel column chromatography.

一种4″-O-glucosyl tenvermectins A/B的用途,4″-O-glucosyl tenvermectinsA/B用于制备防治农林害虫或害螨药物。A use of 4″-O-glucosyl tenvermectins A/B. The 4″-O-glucosyl tenvermectins A/B is used for preparing medicines for preventing and controlling agricultural and forestry pests or pest mites.

作为优选的技术方案,所述农林害虫包括鳞翅目菜蛾科、鳞翅目夜蛾科、鳞翅目枯叶蛾科、鳞翅目螟虫科、鞘翅目叩甲科、垫刃目滑刃总科中的一种或多种;所述害螨包括叶螨类害虫。As a preferred technical solution, the agricultural and forestry pests include Lepidoptera Plutellaidae, Lepidoptera Noctuidae, Lepidoptera Satyridae, Lepidoptera Botryidae, Coleoptera Pyrethidae, Thyropidae Slippery One or more of the superfamily; said pests include spider mites.

作为优选的技术方案,所述4″-O-glucosyl tenvermectins A/B包括单一的4″-O-glucosyl tenvermectin A、单一的4″-O-glucosyl tenvermectin B或两者的混合物。As a preferred technical solution, the 4″-O-glucosyl tenvermectins A/B include a single 4″-O-glucosyl tenvermectin A, a single 4″-O-glucosyl tenvermectin B or a mixture of both.

本发明的4″-O-glucosyl tenvermectins A/B的制备方法,可制备出转化率高 的4″-O-glucosyl tenvermectins A/B。该4″-O-glucosyl tenvermectins A/B在防治农林害虫或害螨时具有优异的效果。The preparation method of 4"-O-glucosyl tenvermectins A/B of the present invention can prepare 4"-O-glucosyl tenvermectins A/B with high conversion rate. The 4″-O-glucosyl tenvermectins A/B has excellent effects in controlling agricultural and forestry pests or harmful mites.

具体实施方式detailed description

下面用具体实例予以说明本发明,应该理解的是,实例是用于说明本发明而不是对本发明的限制,本发明的范围与核心内容依据权利要求书加以确定。The present invention will be described below with specific examples. It should be understood that examples are used to illustrate the present invention rather than to limit the present invention, and the scope and core content of the present invention are determined according to the claims.

实施例1Example 1

1)取保藏号为ATCC 11635的红色糖多孢菌菌种,划线接种于YMS固体培养基上,在28℃的恒温培养箱中培养7天,将活化后的菌种转接于液体培养基中,置于28℃,250rpm的水平摇床中培养40小时,得到种子液,以5%接种量将种子液转接于转化培养基中,培养24小时后每瓶转化培养基中加入500U甲醇溶解的转化底物天维菌素A/B混合物,在28℃,250rpm的条件下继续转化培养150小时,得到发酵液。1) Take the red Saccharopolyspora strain with the preservation number ATCC 11635, inoculate it on the YMS solid medium, culture it in a constant temperature incubator at 28°C for 7 days, and transfer the activated strain to the liquid culture cultured in a horizontal shaker at 28°C and 250rpm for 40 hours to obtain a seed solution, and transferred the seed solution to the transformation medium with a 5% inoculation amount, and added 500 U to each bottle of transformation medium after culturing for 24 hours. The transformation substrate asvermectin A/B mixture dissolved in methanol was continuously transformed and cultured at 28° C. and 250 rpm for 150 hours to obtain a fermentation broth.

2)按上述方法发酵培养得到3L发酵液,将发酵液用6L工业乙醇浸泡过夜,过滤得乙醇提取液。所得提取液在50℃减压浓缩去除乙醇相,然后用等体积乙酸乙酯分别萃取三次得乙酸乙酯萃取液,萃取液在50℃减压条件下浓缩至干,得到5g油状物质。2) Ferment and cultivate according to the above method to obtain 3L of fermented liquid, soak the fermented liquid with 6L of industrial ethanol overnight, and filter to obtain ethanol extract. The resulting extract was concentrated under reduced pressure at 50°C to remove the ethanol phase, and then extracted three times with an equal volume of ethyl acetate to obtain an ethyl acetate extract, which was concentrated to dryness at 50°C under reduced pressure to obtain 5 g of an oily substance.

将所得的油状物质上硅胶柱(粒径100-200目)进行柱层析,用氯仿:甲醇=100:0-60:40(V/V)进行梯度洗脱,通过薄层鉴定(TLC)检测,得到2个组分。将组分2经凝胶(Sephadex LH-20)柱层析得到组分2-1,然后使用半制备柱色谱进行进一步纯化得到纯的4″-O-glucosyl tenvermectin A和4″-O-glucosyl tenvermectin B。Put the obtained oily substance on a silica gel column (particle size 100-200 mesh) for column chromatography, use chloroform:methanol=100:0-60:40 (V/V) for gradient elution, and identify by thin layer (TLC) After detection, 2 components were obtained. Fraction 2 was subjected to gel (Sephadex LH-20) column chromatography to obtain fraction 2-1, and then further purified by semi-preparative column chromatography to obtain pure 4″-O-glucosyl tenvermectin A and 4″-O-glucosyl Tenvermectin B.

其中薄层鉴定方法:转化后的样品和空白对照点于硅胶G薄层板上,在氯仿:甲醇(9:1)的展开剂条件展开,跑完后取出晾干,先紫外灯254nm下观察,再用浓硫酸显色,检视转化结果。Among them, the TLC identification method: the converted sample and the blank control point are placed on the silica gel G thin-layer plate, developed under the developer condition of chloroform:methanol (9:1), take it out and dry it after running, and observe under the ultraviolet lamp 254nm first , and then use concentrated sulfuric acid to develop color and check the conversion results.

半制备柱色谱条件:流动相:甲醇-乙腈-水(45:45:10);色谱柱C18,9.4*250mm;检测波长:244nm;流速:1.5ml/min;柱温:24.4℃;进样量为:60ul。收集保留时间为16min和19.7min的峰得到4″-O-glucosyl tenvermectin A和4″-O-glucosyl tenvermectin B。样品和标准品的配置:称取适量样品和标准品,采用流动相为溶剂,配置成溶液。Semi-preparative column chromatography conditions: mobile phase: methanol-acetonitrile-water (45:45:10); column C18, 9.4*250mm; detection wavelength: 244nm; flow rate: 1.5ml/min; column temperature: 24.4°C; sample injection Quantity: 60ul. The peaks with retention times of 16 min and 19.7 min were collected to obtain 4″-O-glucosyl tenvermectin A and 4″-O-glucosyl tenvermectin B. Configuration of samples and standards: Weigh an appropriate amount of samples and standards, use the mobile phase as a solvent, and configure them into a solution.

3)4″-O-glucosyl tenvermectins A和B的结构鉴定3) Structural identification of 4″-O-glucosyl tenvermectins A and B

通过1D和2D NMR、MS等波谱分析确定4″-O-glucosyl tenvermectins A/B的结构如下:The structure of 4″-O-glucosyl tenvermectins A/B was determined by 1D and 2D NMR, MS and other spectral analysis as follows:

4″-O-glucosyl tenvermectin A的理化性质如下:The physical and chemical properties of 4″-O-glucosyl tenvermectin A are as follows:

性状:白色粉末物质Appearance: White powder substance

溶解性:易溶解于氯仿、丙酮、甲醇,不溶于水Solubility: easily soluble in chloroform, acetone, methanol, insoluble in water

分子式:C51H78O19 Molecular formula: C 51 H 78 O 19

ESI-MS m/z:993.23[M-H]- ESI-MS m/z:993.23[MH] -

UVλmax(EtOH)nm(logε):245(4.67),239(4.63)UVλ max (EtOH)nm(logε):245(4.67), 239(4.63)

IR vmaxcm-1:3387,2930,2875,1721,1646,1450,1383,1340,1305,1270,1170,1062,989IR v max cm -1 : 3387, 2930, 2875, 1721, 1646, 1450, 1383, 1340, 1305, 1270, 1170, 1062, 989

4″-O-glucosyl tenvermectin B的理化性质如下:The physical and chemical properties of 4″-O-glucosyl tenvermectin B are as follows:

性状:白色粉末物质Appearance: White powder substance

溶解性:易溶解于氯仿、丙酮、甲醇,不溶于水Solubility: easily soluble in chloroform, acetone, methanol, insoluble in water

分子式:C52H80O19 Molecular formula: C 52 H 80 O 19

ESI-MS m/z:1007.22[M-H]- ESI-MS m/z:1007.22[MH] -

UVλmax(EtOH)nm(logε):245(4.50),239(4.46)UVλ max (EtOH)nm(logε):245(4.50), 239(4.46)

IR vmaxcm-1:3369,2928,2873,1716,1637,1452,1382,1340,1304,1268,1168,1118,1064,985IR v max cm -1 : 3369, 2928, 2873, 1716, 1637, 1452, 1382, 1340, 1304, 1268, 1168, 1118, 1064, 985

1H NMR(CDCl3,400MHz)和13C NMR(CDCl3,100MHz)见表1。See Table 1 for 1 H NMR (CDCl 3 , 400 MHz) and 13 C NMR (CDCl 3 , 100 MHz).

表1 4″-O-glucosyl tenvermectins A和B在CDCl3中的核磁数据Table 1 NMR data of 4″-O-glucosyl tenvermectins A and B in CDCl 3

(氢谱,400MHz;碳谱,100MHz)(H spectrum, 400MHz; Carbon spectrum, 100MHz)

实施例2Example 2

取保藏号为ATCC 11635的红色糖多孢菌种,划线接种于YMS固体培养基上,在28℃的恒温培养箱中培养7天,将活化后的菌种转接于液体培养基中,置于28℃,250rpm的水平摇床中培养40小时,得到种子液,以5%接种量将种子液转接于转化培养基(M-1)中,培养24小时后每瓶转化培养基中加入甲醇溶解的转化底物天维菌素A/B混合物,在28℃,250rpm的条件下继续转化培养150小时,乙酸乙酯萃取发酵液,后经HPLC检测得4″-O-glucosyltenvermectins A和B转化率分别为5.77%和7.69%。Take the red Saccharopolyspora strain with the preservation number ATCC 11635, inoculate it on the YMS solid medium, culture it in a constant temperature incubator at 28°C for 7 days, transfer the activated strain into the liquid medium, Placed at 28°C, cultivated in a horizontal shaker at 250rpm for 40 hours to obtain a seed liquid, and transferred the seed liquid to the transformation medium (M-1) with a 5% inoculum size, and put it in each bottle of transformation medium after 24 hours of cultivation Add the transformation substrate asvermectin A/B mixture dissolved in methanol, continue the transformation culture for 150 hours at 28°C and 250rpm, extract the fermentation broth with ethyl acetate, and then detect 4″-O-glucosyltenvermectins A and B conversions were 5.77% and 7.69%, respectively.

实施例3Example 3

取保藏号为ATCC 11635的红色糖多孢菌种,划线接种于YMS固体培养基上,在28℃的恒温培养箱中培养7天,将活化后的菌种转接于液体培养基中,置于28℃,250rpm的水平摇床中培养40小时,得到种子液,以5%接种量将种子液转接于转化培养基(M-2)中,培养24小时后每瓶转化培养基中加入乙醇溶解的转化底物天维菌素A/B混合物,在28℃,250rpm的条件下继续转化培养150小时,乙醚萃取发酵液,后经HPLC检测得4″-O-glucosyltenvermectins A和B转化率分别为4.20%和11.15%。Take the red Saccharopolyspora strain with the preservation number ATCC 11635, inoculate it on the YMS solid medium, culture it in a constant temperature incubator at 28°C for 7 days, transfer the activated strain into the liquid medium, Placed at 28°C, cultivated in a horizontal shaker at 250rpm for 40 hours to obtain a seed solution, and transferred the seed solution to the transformation medium (M-2) with a 5% inoculum size, and put it in each bottle of transformation medium after culturing for 24 hours Add the transformation substrate asvermectin A/B mixture dissolved in ethanol, continue the transformation culture at 28°C and 250rpm for 150 hours, extract the fermentation broth with ether, and detect the transformation of 4″-O-glucosyltenvermectins A and B by HPLC The rates were 4.20% and 11.15%, respectively.

实施例4Example 4

取保藏号为ATCC 11635的红色糖多孢菌种,划线接种于YMS固体培养基上,在28℃的恒温培养箱中培养7天,将活化后的菌种转接于液体培养基中,置于28℃,250rpm的水平摇床中培养40小时,得到种子液,以5%接种量将种子液转接于转化培养基(M-3)中,培养24小时后每瓶转化培养基中加入DMSO溶解的转化底物天维菌素A/B混合物,在28℃,250rpm的条件下继续转化培养150小时,石油醚萃取发酵液,后经HPLC检测得4″-O-glucosyltenvermectins A和B转化率分别为7.78%和14.24%。Take the red Saccharopolyspora strain with the preservation number ATCC 11635, inoculate it on the YMS solid medium, culture it in a constant temperature incubator at 28°C for 7 days, transfer the activated strain into the liquid medium, Placed at 28°C, cultivated in a horizontal shaker at 250rpm for 40 hours to obtain a seed liquid, and transferred the seed liquid to the transformation medium (M-3) with a 5% inoculum size, and put it in each bottle of transformation medium after culturing for 24 hours Add the DMSO-dissolved transformation substrate asvermectin A/B mixture, continue the transformation culture at 28°C and 250rpm for 150 hours, extract the fermentation broth with petroleum ether, and then detect 4″-O-glucosyltenvermectins A and B by HPLC The conversions were 7.78% and 14.24%, respectively.

实施例5Example 5

取保藏号为ATCC 11635的红色糖多孢菌种,划线接种于YMS固体培养基上,在28℃的恒温培养箱中培养7天,将活化后的菌种转接于液体培养基中,置于28℃,250rpm的水平摇床中培养40小时,得到种子液,以5%接种量将种子液转接于转化培养基(M-4)中,培养24小时后每瓶转化培养基中加入甲醇溶解的转化底物天维菌素A/B混合物,在28℃,250rpm的条件下继续转化培养150小时,二氯甲烷萃取发酵液,后经HPLC检测得4″-O-glucosyltenvermectins A和B转化率分别为9.74%和19.8%。Take the red Saccharopolyspora strain with the preservation number ATCC 11635, inoculate it on the YMS solid medium, culture it in a constant temperature incubator at 28°C for 7 days, transfer the activated strain into the liquid medium, Placed at 28°C and cultivated in a horizontal shaker at 250rpm for 40 hours to obtain a seed solution, which was transferred to the transformation medium (M-4) with a 5% inoculum size, and was placed in each bottle of transformation medium after 24 hours of cultivation. Add the transformation substrate asvermectin A/B mixture dissolved in methanol, continue the transformation culture for 150 hours at 28°C and 250rpm, extract the fermentation broth with dichloromethane, and then detect 4″-O-glucosyltenvermectins A and B conversions were 9.74% and 19.8%, respectively.

实施例6Example 6

4″-O-glucosyl tenvermectins A和B对朱砂叶螨的生物活性Biological Activity of 4″-O-glucosyl tenvermectins A and B against Tetranychus cinnabarinus

供试药剂:98%(w/w)4″-O-glucosyl tenvermectins A、B,98%(w/w)tenvermectin A:分别称取1g 98%4″-O-glucosyl tenvermectins A和B加入烧杯 中,并加入93g甲醇和6g表面活性剂壬基酚聚氧乙烯醚,制成浓度为10000mg/L的制剂,用水稀释成浓度为0.005、0.01、0.02、0.04、0.08mg/L的药液供试。Test agent: 98% (w/w) 4″-O-glucosyl tenvermectins A, B, 98% (w/w) tenvermectin A: Weigh 1g of 98% 4″-O-glucosyl tenvermectins A and B respectively into the beaker , and add 93g of methanol and 6g of surfactant nonylphenol ethoxylate to make a preparation with a concentration of 10000mg/L, and dilute it with water to provide a drug solution with a concentration of 0.005, 0.01, 0.02, 0.04, and 0.08mg/L. try.

供试生物:朱砂叶螨(Tetranychus cinnabarinus):在人工气候室条件下[(26±1)℃,RH(70±5)%,H/D14],接种于蚕豆苗上培养。Organisms to be tested: Tetranychus cinnabarinus: Inoculated on faba bean seedlings under the conditions of artificial climate chamber [(26±1)°C, RH (70±5)%, H/D14].

实验方法:采用叶碟浸虫浸液法:选择室内饲养、生理状态一致的成螨虫。选取生长一致的蚕豆叶片,用打孔器做成直径2cm叶碟,叶背朝上置于塑料皿中心的脱脂棉上,每皿3片叶蝶,用小号毛笔挑接成螨接种到叶碟上,每叶碟30头,并加适量水,放于(26±1)℃,光照强度3000~4500lx、14h/d,RH 50%~75%的培养室内。2h后于体视显微镜下检查成螨数,每皿叶碟上螨的数量不低于20头。制备好的质量浓度0.005、0.01、0.02、0.04、0.08mg/L的药剂放于烧杯中,用镊子夹住叶片从低浓度到高浓度依次浸药,浸药时间为5s,对照用蒸馏水处理雌成螨,每个质量浓度为一处理,每处理重复3次。待叶片上的药剂晾干,将处理过的叶碟置于(26±1)℃和14h光周期的人工气候室培养24h,并于培养皿中加少量水保湿。浸药后螨虫非常活跃,处理后5-8小时就开始减慢活动,12-24小时后虫体静止。死亡判定标准:检查时用毛笔轻触螨体,完全不动者判定为死亡。以朱砂叶螨为试虫,对4″-O-glucosyltenvermectins A和B的室内活性进行了测定,并以tenvermectin A为对照药剂,比较了4″-O-glucosyl tenvermectins A和B与tenvermectin A的活性。Experimental method: Leaf disc dipping method: select adult mites that are reared indoors and have the same physiological state. Select broad bean leaves with consistent growth, use a puncher to make leaf discs with a diameter of 2 cm, and place the leaves on the absorbent cotton in the center of a plastic dish with the back of the leaves facing up. Three leaf butterflies are picked in each dish, and the adult mites are picked and inoculated into the leaf discs with a small brush On top, 30 discs per leaf, add appropriate amount of water, and place in a cultivation room at (26±1)°C, light intensity 3000-4500lx, 14h/d, RH 50%-75%. After 2 hours, the number of adult mites was checked under a stereo microscope, and the number of mites on each leaf dish was not less than 20. The prepared medicines with mass concentrations of 0.005, 0.01, 0.02, 0.04, and 0.08mg/L were placed in beakers, and the leaves were clamped with tweezers to soak in order from low concentration to high concentration for 5 seconds. Adult mites, each mass concentration is a treatment, and each treatment is repeated 3 times. After the chemicals on the leaves are dried, the treated leaf discs are placed in an artificial climate chamber at (26±1)°C and a photoperiod of 14 hours for 24 hours, and a small amount of water is added to the culture dish to moisturize. The mites are very active after soaking the medicine, and they start to slow down their activities 5-8 hours after treatment, and the mites are still after 12-24 hours. Criteria for judging the death: lightly touch the mite body with a brush during the inspection, and those who do not move at all are judged as dead. The indoor activities of 4″-O-glucosyltenvermectins A and B were measured with Tetranychus cinnabarinus as the test insect, and the activities of 4″-O-glucosyl tenvermectins A and B and tenvermectin A were compared with tenvermectin A as the control agent .

结论:实验结果见表2,tenvermectin A对朱砂叶螨的LC50为0.0084mg/L,转化后产物4″-O-glucosyl tenvermectins A/B对朱砂叶螨的LC50分别为0.0156mg/L,0.0113mg/L,转化后产物4″-O-glucosyl tenvermectins A/B与tenvermectin A对朱砂叶螨的活性无显著性差异。Conclusion: See Table 2 for the experimental results. The LC50 of tenvermectin A against Tetranychus cinnabarinus is 0.0084mg/L, and the LC50 of the transformed product 4″-O-glucosyl tenvermectins A/B against Tetranychus cinnabarinus are 0.0156mg/L and 0.0113mg respectively /L, there was no significant difference in the activity of the transformed product 4″-O-glucosyl tenvermectins A/B and tenvermectin A against Tetranychus cinnabarinus.

表2:4″-O-glucosyl tenvermectins A/B对朱砂叶螨的活性Table 2: Activity of 4″-O-glucosyl tenvermectins A/B against Tetranychus cinnabarinus

实施例7Example 7

4″-O-glucosyl tenvermectins A和B对松材线虫的活性测定Activity determination of 4″-O-glucosyl tenvermectins A and B against pine xylophilus

试验药剂:4″-O-glucosyl tenvermectins A/B来自上述实施例,tenvermectin A来自浙江海正药业股份有限公司。Test agents: 4″-O-glucosyl tenvermectins A/B are from the above examples, and tenvermectin A is from Zhejiang Hisun Pharmaceutical Co., Ltd.

供试生物:以松材线虫为试虫Test organisms: pine xylophilus as the test insect

试验方法:采用浸液法。每种药剂设立5个质量浓度1、2、5、10、20mg/L,每浓度重复3次,24h统计实验结果。Test method: use immersion method. Five mass concentrations of 1, 2, 5, 10, and 20 mg/L were established for each drug, and each concentration was repeated 3 times, and the experimental results were counted within 24 hours.

试验结果:各种药剂对松材线虫的毒力见表3。tenvermectin A对松材线虫的LC50为2.4391mg/L,转化后产物4″-O-glucosyl tenvermectins A/B对松材线虫的LC50分别为6.7984mg/L,5.7980mg/L,转化后产物4″-O-glucosyl tenvermectins A/B对松材线虫的活性与tenvermectin A相比,无显著性差异。Test results: See Table 3 for the toxicity of various pesticides to pine xylophilus. The LC50 of tenvermectin A to pine wood nematode is 2.4391mg/L, and the converted product 4″-O-glucosyl tenvermectins A/B to pine wood nematode LC50 are 6.7984mg/L, 5.7980mg/L, and the transformed product is 4″ - O-glucosyl tenvermectins A/B activity against B. xylophilus compared with tenvermectin A, there was no significant difference.

表3:4″-O-glucosyl tenvermectins A/B对松材线虫的活性Table 3: Activity of 4″-O-glucosyl tenvermectins A/B against pine xylophilus

实施例8Example 8

4″-O-glucosyl tenvermectins A和B对小菜蛾的活性测定Activity Determination of 4″-O-glucosyl tenvermectins A and B against Plutella xylostella

试验药剂:4″-O-glucosyl tenvermectins A/B来自上述实施例,tenvermectin A来自浙江海正药业股份有限公司。Test agents: 4″-O-glucosyl tenvermectins A/B are from the above examples, and tenvermectin A is from Zhejiang Hisun Pharmaceutical Co., Ltd.

供试生物:以小菜蛾为试虫Test organisms: Plutella xylostella as test insect

试验方法:采用药膜法。每种药剂设立5个质量浓度25、50、100、200和250mg/L,每浓度重复3次,24h统计实验结果。Test method: the drug film method is used. Five mass concentrations of 25, 50, 100, 200 and 250 mg/L were established for each drug, each concentration was repeated 3 times, and the experimental results were counted within 24 hours.

试验结果:各种药剂对小菜蛾的毒力见表4。tenvermectin A对小菜蛾在250mg/L的校正死亡率为79.62%,转化后产物4″-O-glucosyl tenvermectins A/B对小菜蛾在250mg/L的校正死亡率分别为70.21%、74.87%,转化后产物4″-O-glucosyltenvermectins A/B对小菜蛾活性与tenvermectin A相比,无显著性差异。Test results: See Table 4 for the toxicity of various pesticides to diamondback moth. The corrected mortality of tenvermectin A to Plutella xylostella at 250mg/L is 79.62%, and the corrected mortality of the transformed product 4″-O-glucosyl tenvermectins A/B to Plutella xylostella at 250mg/L is 70.21%, 74.87%, respectively. Compared with tenvermectin A, the latter product 4″-O-glucosyltenvermectins A/B has no significant difference in activity against diamondback moth.

表4:4″-O-glucosyl tenvermectins A/B对小菜蛾的活性Table 4: Activity of 4″-O-glucosyl tenvermectins A/B against diamondback moth

实施例9Example 9

4″-O-glucosyl tenvermectins A和B对竹螟的活性测定Determination of the activity of 4″-O-glucosyl tenvermectins A and B against the bamboo borer

试验药剂:4″-O-glucosyl tenvermectins A/B来自上述实施例,tenvermectin A来自浙江海正药业股份有限公司。Test agents: 4″-O-glucosyl tenvermectins A/B are from the above examples, and tenvermectin A is from Zhejiang Hisun Pharmaceutical Co., Ltd.

供试生物:以竹螟为试虫Test organisms: Take bamboo borer as the test insect

试验方法:采用浸渍法。每种药剂设立5个质量浓度1、2、5、10和20mg/L,每浓度重复3次,24h统计实验结果。Test method: using dipping method. Five mass concentrations of 1, 2, 5, 10 and 20 mg/L were established for each drug, each concentration was repeated 3 times, and the experimental results were counted within 24 hours.

试验结果:各种药剂对竹螟的毒力见表5。tenvermectin A对竹螟在20mg/L的校正死亡率为77.52%,转化后产物4″-O-glucosyl tenvermectins A/B对竹螟在20mg/L的校正死亡率分别为68.56%,70.62%,转化后产物4″-O-glucosyl tenvermectins A/B对竹螟的活性与tenvermectin A相比,无显著性差异。Test results: Table 5 shows the toxicity of various pesticides to bamboo borer. The corrected mortality of tenvermectin A to bamboo borer at 20mg/L was 77.52%, and the corrected mortality of the transformed product 4″-O-glucosyl tenvermectins A/B to bamboo borer at 20mg/L was 68.56%, 70.62%, respectively. Compared with tenvermectin A, the latter product 4″-O-glucosyl tenvermectins A/B had no significant difference in activity against bamboo borer.

表5:4″-O-glucosyl tenvermectins A/B对竹螟的活性Table 5: Activity of 4″-O-glucosyl tenvermectins A/B against bamboo borer

本发明4″-O-glucosyl tenvermectins A/B的制备方法,可制备出转化率高的4″-O-glucosyl tenvermectins A/B。该4″-O-glucosyl tenvermectins A/B在防治农林害虫或害螨时具有优异的效果。The preparation method of the 4"-O-glucosyl tenvermectins A/B of the present invention can prepare the 4"-O-glucosyl tenvermectins A/B with a high conversion rate. The 4″-O-glucosyl tenvermectins A/B has excellent effects in controlling agricultural and forestry pests or harmful mites.

本发明4″-O-glucosyl tenvermectins A/B的用途已经通过具体的实例进行了描述,本领域技术人员可借鉴本发明内容,适当改变原料、工艺条件等环 节来实现相应的其它目的,其相关改变都没有脱离本发明的内容,所有类似的替换和改动对于本领域技术人员来说是显而易见的,都被视为包括在本发明的范围之内。The use of the 4″-O-glucosyl tenvermectins A/B of the present invention has been described through specific examples. Those skilled in the art can refer to the content of the present invention and appropriately change the raw materials, process conditions and other links to achieve other corresponding purposes. The changes do not depart from the content of the present invention, and all similar substitutions and modifications that are obvious to those skilled in the art are deemed to be included within the scope of the present invention.

以上所述的实施例只是本发明较佳的方案,并非对本发明作任何形式上的限制,在不超出权利要求所记载的技术方案的前提下还有其它的变体及改型。The embodiments described above are only preferred solutions of the present invention, and do not limit the present invention in any form. There are other variations and modifications on the premise of not exceeding the technical solutions described in the claims.

Claims (10)

1.4 " preparation method of-O-glucosyl tenvermectins A/B, it is characterised in that comprise the steps:
1) red saccharopolyspora seed liquor is prepared: take the S. erythraea strain that preserving number is ATCC 11635 Saccharopolyspora erythraea, streak inoculation is on YMS solid medium, in the constant incubator of 20-28 DEG C Cultivate 5-7 days, by the strain transfer after activation in fluid medium, be placed in 20-28 DEG C, the horizontal shaker of 250rpm is cultivated 40 hours, obtain seed liquor;
2) 4 are prepared "-O-glucosyl tenvermectins A/B: seed liquor is transferred in converting in culture medium, cultivate 24 little The conversion of substrate sky dimension rhzomorph A/B that time after, addition is dissolved with organic solvent, at 20-28 DEG C, converts under conditions of 250rpm and cultivates After 150 hours, obtain fermentation liquid;4 are obtained through chromatographic isolation after using extractant extractive fermentation liquid and reclaiming extractant "-O- Glucosyl tenvermectins A/B sterling;Described 4 " chemical constitution of-O-glucosyl tenvermectins A/B It is characterized as:
The most according to claim 14 " preparation method of-O-glucosyl tenvermectinsA/B, it is characterised in that Described step 1) in the preparation method of fluid medium be: take glucose 10g, yeast extract 2g, beef extract 2g and egg White peptone 3g, after being settled to 1000ml with distilled water, regulates pH to 7.0 with the NaOH of 1mol/l, uses 250ml triangular flask every bottle point Dress 40ml, at 121 DEG C, sterilizing 20min under the conditions of 0.15MPa.
The most according to claim 14 " preparation method of-O-glucosyl tenvermectinsA/B, it is characterised in that Described step 2) conversion culture medium include that M-1 culture medium that carbon-nitrogen ratio is different, M-2 culture medium, M-3 culture medium and M-4 cultivate Base, wherein,
The component of M-1 culture medium is: glucose 5g, brown sugar 10g, tryptone 5g, yeast extract 2.5g, ethylenediaminetetraacetic acid Sodium 0.036g, glycine betaine 1.2g and sodium propionate 0.11g;
The component of M-2 culture medium is: cerelose 44g, Carnis Bovis seu Bubali cream 5.0g, peptone 6.0g, yeast extract 4g, casein Fried soybean cake powder 11.0g, NaCl 1.5g and K of peptone 3.0g, heat2HPO40.5g;
The component of M-3 culture medium is: glucose 50g, soybean cake powder 5g, yeast extract 5g, peptone 4g, NaCl 5g, K2HPO42g and KH2PO41g;
The component of M-4 culture medium is: cerelose 50g, NaCl 5g, (NH4)2SO4 2g、CaCO36g and Semen sojae atricolor powder 30g;
After above component distilled water is settled to 1000ml, regulate pH to 7.0-7.2,250ml triangular flask with the NaOH of 1mol/l Every bottle of subpackage 40ml, at 121 DEG C, sterilizing 20min under the conditions of 0.15MPa.
The most according to claim 14 " preparation method of-O-glucosyl tenvermectinsA/B, it is characterised in that Described step 2) organic solvent include one or more in methanol, ethanol, DMSO.
The most according to claim 14 " preparation method of-O-glucosyl tenvermectinsA/B, it is characterised in that Described step 2) extractant include ethyl acetate, n-butyl alcohol, isobutyl acetate, ether, petroleum ether, dichloromethane or three chloromethanes One or more in alkane.
The most according to claim 14 " preparation method of-O-glucosyl tenvermectins A/B, its feature exists In, described step 2) purification include that reversed-phase high-performance liquid chromatography chromatographs.
The most according to claim 64 " preparation method of-O-glucosyl tenvermectins A/B, its feature exists In, described step 2) purification also include silica gel column chromatography.
8. an according to claim 14 " purposes of-O-glucosyl tenvermectins A/B, its feature exists In, 4 "-O-glucosyl tenvermectins A/B is used for preparing preventing and treating agriculture and forestry injurious insect or evil demodicid mite medicine.
The most according to claim 84 " purposes of-O-glucosyl tenvermectins A/B, it is characterised in that institute State agriculture and forestry injurious insect and include that Lepidoptera diamond-back moth section, Lepidoptera Noctuidae, Lepidoptera Lasiocampidae, Lepidoptera snout moths larva section, coleoptera are kowtowed One or more in first section, Tylenchida Aphelenchoidea;Described harmful demodicid mite includes spider mite kind insect.
The most according to claim 84 " purposes of-O-glucosyl tenvermectins A/B, it is characterised in that institute State 4 "-O-glucosyl tenvermectins A/B includes single 4 "-O-glucosyl tenvermectinA, single 4 "-O-glucosyl tenvermectin B or both mixture.
CN201610374253.4A 2016-05-30 2016-05-30 The Preparation method and use of it dimension streptozotocin derivative Pending CN106167815A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610374253.4A CN106167815A (en) 2016-05-30 2016-05-30 The Preparation method and use of it dimension streptozotocin derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610374253.4A CN106167815A (en) 2016-05-30 2016-05-30 The Preparation method and use of it dimension streptozotocin derivative

Publications (1)

Publication Number Publication Date
CN106167815A true CN106167815A (en) 2016-11-30

Family

ID=57359159

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610374253.4A Pending CN106167815A (en) 2016-05-30 2016-05-30 The Preparation method and use of it dimension streptozotocin derivative

Country Status (1)

Country Link
CN (1) CN106167815A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106538556A (en) * 2016-09-30 2017-03-29 赵青娇 A kind of biological pesticide of preventing and treating root-knot nematode
CN107258798A (en) * 2016-04-07 2017-10-20 浙江海正药业股份有限公司 Its dimension rhzomorph is used for the purposes for controlling harmful insect in farm-forestry crop
WO2018177146A1 (en) * 2017-04-01 2018-10-04 浙江海正药业股份有限公司 Recombinant microorganism for expressing tenvermectin b, preparation method therefor and use thereof
WO2019228260A1 (en) * 2018-05-28 2019-12-05 浙江海正药业股份有限公司 Crystal form of tenvermectin b, preparation method therefor, and use thereof
CN113461757A (en) * 2021-06-25 2021-10-01 湖州师范学院 Preparation method and application of novel sixteen-membered macrolide
CN113817008A (en) * 2021-07-15 2021-12-21 湖州师范学院 Preparation method and application of novel succinyl sixteen-membered macrolide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101037441A (en) * 2007-01-17 2007-09-19 东北农业大学 Macrolide compound and preparation method thereof
WO2016074221A1 (en) * 2014-11-14 2016-05-19 浙江海正药业股份有限公司 Spinosad heterologous expression strain and construction method thereof and use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101037441A (en) * 2007-01-17 2007-09-19 东北农业大学 Macrolide compound and preparation method thereof
WO2016074221A1 (en) * 2014-11-14 2016-05-19 浙江海正药业股份有限公司 Spinosad heterologous expression strain and construction method thereof and use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SCHULMAN, M.等: "Microbial conversion of avermectins by Saccharopolyspora erythraea: glycosylation at C-4" and C-4""", 《ANTIMICROBIAL AGENTS AND CHEMOTHERAPY》 *
杨波等: "新化合物天维菌素的杀虫杀螨活性", 《农药学学报》 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107258798A (en) * 2016-04-07 2017-10-20 浙江海正药业股份有限公司 Its dimension rhzomorph is used for the purposes for controlling harmful insect in farm-forestry crop
CN106538556A (en) * 2016-09-30 2017-03-29 赵青娇 A kind of biological pesticide of preventing and treating root-knot nematode
WO2018177146A1 (en) * 2017-04-01 2018-10-04 浙江海正药业股份有限公司 Recombinant microorganism for expressing tenvermectin b, preparation method therefor and use thereof
CN108660101A (en) * 2017-04-01 2018-10-16 浙江海正药业股份有限公司 Express recombinant microorganism, the preparation method and its usage of day dimension rhzomorph B
CN108660101B (en) * 2017-04-01 2021-07-09 浙江海正药业股份有限公司 Recombinant microorganism expressing ivermectin B, preparation method and application thereof
WO2019228260A1 (en) * 2018-05-28 2019-12-05 浙江海正药业股份有限公司 Crystal form of tenvermectin b, preparation method therefor, and use thereof
AU2019276480B2 (en) * 2018-05-28 2022-01-20 Shenzhen Tenver Biopharm Co., Ltd. Crystal form of tenvermectin B, preparation method therefor, and use thereof
US11912717B2 (en) 2018-05-28 2024-02-27 Shenzhen Tenver Biopharm Co., Ltd. Crystal form of tenvermectin B, preparation method therefor, and use thereof
CN113461757A (en) * 2021-06-25 2021-10-01 湖州师范学院 Preparation method and application of novel sixteen-membered macrolide
CN113461757B (en) * 2021-06-25 2023-08-22 湖州师范学院 Preparation method and application of novel sixteen-membered macrocyclic lactone
CN113817008A (en) * 2021-07-15 2021-12-21 湖州师范学院 Preparation method and application of novel succinyl sixteen-membered macrolide

Similar Documents

Publication Publication Date Title
CN106167815A (en) The Preparation method and use of it dimension streptozotocin derivative
US10028507B2 (en) Sixteen-membered macrolide compound and applications thereof
FI107266B (en) New A83543 compounds and process for their preparation
NO176914B (en) Macrolide Compounds, Methods of their Preparation, Biological Purified Culture and Preparations Containing Macrolide Compounds
CZ286032B6 (en) Indole diterpene, process of its preparation, pharmaceutical preparation and biologically pure culture
NO143484B (en) STEERABLE, ENGINE WHEELS.
CN113142245B (en) Synergistic prevention and treatment of common thrips by Beauveria bassiana SB038 and spinetoram
CN103740606A (en) Streptomyces phytohabitans, method for producing new antibiotics Novonestmycin from Streptomyces phytohabitans, and application of Novonestmycin
CN104098585B (en) Mibemycin analogue, its preparation method and application
KR20180035435A (en) Composition for controlling nematode comprising grammicin compound as effective component and uses thereof
CN106810601B (en) A kind of Destruxin class depsipeptide derivative and its preparation method and application
CN106010980A (en) Endophytic fungus paraconiothyrium brasiliense strain and application thereof
CN102676393B (en) Saccharopolyspora spinosa for producing spinosad and culture and application of saccharopolyspora spinosa
CN103242338B (en) Macrolide compound as well as preparation method and application thereof
CN113461757B (en) Preparation method and application of novel sixteen-membered macrocyclic lactone
CN113817008B (en) Preparation method and application of novel succinyl hexadecanoic macrolide
CN115806907A (en) Preparation and application of a deep-sea streptomyces and its antifeedant and antifungal active substances
CN109699683A (en) A kind of talcum matrix Java cordyceps sinensis spore preparation
JPH037289A (en) Vermicidic bioconverted product
CN103641810A (en) Polyketone compound, preparation method and application thereof
CN103361276B (en) Saccharopolyspora spinosa HBERC-25376, culturing method thereof as well as separation method and application of active substances thereof
CN103540535B (en) Intracellular lipase producing strains and application thereof and screening method and using method
CN116478880B (en) A strain of Amycoticola tucumiensis KC 316 and its application
CN107827950A (en) A kind of Trichomide classes Cyclopeptide derivatives and its preparation method and application
CN111909166A (en) Two new milbemycins, preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20161130

RJ01 Rejection of invention patent application after publication